Development and analytical performance of automated tests for antithrombin III and plasminogen on the Du Pont aca analyzer.
We describe assays for functional antithrombin III (AT III) and plasminogen in plasma with the Du Pont aca discrete clinical analyzer. Both are two-stage kinetic assays, based on synthetic substrate methodologies, and require 20-microL sample volumes. In the AT III assay the sample is incubated with excess thrombin and heparin to form the functionally inactive AT III-thrombin complex. Residual thrombin is measured through its rate of hydrolysis of a lysine thioester and is inversely related to analyte concentration. In the plasminogen assay excess streptokinase is reacted with the sample to form an enzymatically active complex. The substrate hydrolysis rate of this complex is measured, which is linearly related to the concentration of plasminogen in the sample. Reaction conditions for both assays were optimized by univariate and response surface techniques. The assay for AT III has a range of 0 to 150% of the value for normal human plasma (% NHP) with a CV of 3% at 80% NHP. The plasminogen assay is linear from 25 to 200% NHP with a CV of less than 2% at 80% NHP. No significant interferences with either method by common blood components or drugs were found.
D000990:Antithrombin III / Q000032:analysis*; D001322:Autoanalysis / Q000295:instrumentation / Q000379:methods; D004228:Dithionitrobenzoic Acid; D006493:Heparin; D006801:Humans; D010958:Plasminogen / Q000032:analysis*; D013300:Streptokinase / Q000378:metabolism; D013917:Thrombin
D000990:Antithrombin III; D010958:Plasminogen; D006493:Heparin; D004228:Dithionitrobenzoic Acid; D013300:Streptokinase; D013917:Thrombin